» Articles » PMID: 12737879

Diabetic Foot Ulcers

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2003 May 10
PMID 12737879
Citations 244
Authors
Affiliations
Soon will be listed here.
Abstract

Ulceration of the foot in diabetes is common and disabling and frequently leads to amputation of the leg. Mortality is high and healed ulcers often recur. The pathogenesis of foot ulceration is complex, clinical presentation variable, and management requires early expert assessment. Interventions should be directed at infection, peripheral ischaemia, and abnormal pressure loading caused by peripheral neuropathy and limited joint mobility. Despite treatment, ulcers readily become chronic wounds. Diabetic foot ulcers have been neglected in health-care research and planning, and clinical practice is based more on opinion than scientific fact. Furthermore, the pathological processes are poorly understood and poorly taught and communication between the many specialties involved is disjointed and insensitive to the needs of patients.

Citing Articles

DIAMACC: protocol of a prospective diagnostic accuracy study of the maximal systolic acceleration to detect peripheral arterial disease in patients with diabetes-related foot ulceration in the Netherlands.

Willems S, Schepers A, Hamming J, Brouwers J BMJ Open. 2025; 14(12):e086629.

PMID: 39806662 PMC: 11667405. DOI: 10.1136/bmjopen-2024-086629.


Material Technologies for Improved Diabetic Foot Ulcer (DFU) Treatment: A Questionnaire Study of Healthcare Professionals' Needs.

Vargas Guerrero M, Vonken L, Peters E, Lucchesi J, Arts J Biomedicines. 2024; 12(11).

PMID: 39595050 PMC: 11592356. DOI: 10.3390/biomedicines12112483.


Skin graft monitoring using forward-looking infrared thermal imaging.

Hwang Y, Byeon J, Lee D, Kim J, Lim S, Choi H Int Wound J. 2024; 21(11):e70107.

PMID: 39572006 PMC: 11581778. DOI: 10.1111/iwj.70107.


Targeting ferroptosis promotes diabetic wound healing via Nrf2 activation.

Wang T, Zheng Y, Zhang J, Wu Z Heliyon. 2024; 10(19):e37477.

PMID: 39421383 PMC: 11483302. DOI: 10.1016/j.heliyon.2024.e37477.


Impact of SGLT2 inhibitors on lower limb complications: a mendelian randomization perspective.

Chen B, Huang M, Pu B, Dong H Front Pharmacol. 2024; 15:1401103.

PMID: 39355774 PMC: 11442421. DOI: 10.3389/fphar.2024.1401103.